Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Stem Cell Banking Market worth 9.30 Billion USD by 2023 | MarketsandMarkets

 



(PharmaNewsWire.Com, February 15, 2019 ) Factors such as increase in hematopoietic stem cell transplantation (HSCT) procedures, increasing investments in stem cell-based research, and growing awareness on the therapeutic potential of stem cells are driving the growth of the stem cell banking market.



Based on source, the placental stem cells segment is expected to witness the highest growth during the forecast period



Based on source, the stem cell banking market is segmented into placental, bone marrow-derived, adipose tissue-derived, human embryo-derived, dental pulp, and other stem cell sources. The placental stem cells segment is projected to grow at the highest rate during the forecast period; owing to the global rise in the number of placental and cord banks (especially the US and Europe) coupled with growing public awareness about the therapeutic potential of stem cells.



Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220680183



Based on application, the personalized banking applications segment is expected to account for the largest share of the stem cell banking market in 2018



By application, the stem cell banking market is segmented into personalized banking, clinical, and research applications. The personalized banking applications segment is poised to be the fastest-growing segment due to the premium pricing of service plans charged by service providers and specific advantages offered by personalized banking over community & public banking, growing adoption of precision medicine across developed countries, rising prevalence of blood and immune system-related disorders among newborns and children, and increasing public concerns regarding the clinical abuse of stored stem cell samples.



By service type, sample preservation & storage segment is expected to witness the highest growth during the forecast period



On the basis of service type, the stem cell banking market is segmented into sample collection & transportation, sample processing, sample analysis, and sample preservation & storage. The sample preservation & storage segment is expected to be the fastest growing segment during the forecast period owing to the growing adoption of stem cell banking services in major countries coupled with the rising number of stem cell banks across emerging countries, rising public awareness about the therapeutic applications of stem cells, increasing number of hematopoietic stem cell transplantations, increasing stem cell-based research, and high market penetration of stem cell banking services in major healthcare markets.



North America is expected to dominate the stem cell banking market in 2018



Geographically, the stem cell banking market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest market share in 2018. The expanding network of stem cell banking services, ongoing approval of stem cell lines for various disease treatment, recent technological advancements in the field of stem cell collection and preservation techniques, rising public-private investments for stem cell researches, growing number of stem cell transplantation procedures, and increasing public preference for private stem cell banking over public stem cell banks are driving the growth of the stem cell banking market in North America.



Get the Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=220680183



As of 2017, major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).



About MarketsandMarkets™



MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.



Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.



MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.



Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com

MarketsandMarkets

Mr. Shelly Singh

1-888-600-6441

sales@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC